Literature DB >> 12074827

Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease.

Natàlia Ferré1, Mònica Tous, Antoni Paul, Alberto Zamora, Juan J Vendrell, Alfredo Bardají, Jordi Camps, Cristobal Richart, Jorge Joven.   

Abstract

OBJECTIVES: To assess whether paraoxonase (PON1) polymorphisms at positions 55 and 192 and/or their phenotypic expressions influence the risk of myocardial infarction (MI) in Spanish population. DESIGN AND METHODS: Two hundred and fifteen male survivors of a MI and their age-matched controls were included in the study. Lipids, apolipoproteins (apo) A-I and B, PON1 activity on paraoxon and phenylacetate and PON1 polymorphisms were determined.
RESULTS: Genotype distribution was similar in patients and controls. Enzyme activities were lower in patients, but multiple logistic regression analysis did not show any independent association with a higher risk of MI.
CONCLUSION: None of the PON1 polymorphisms or their corresponding measured activities are independent risk factors for MI in our population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074827     DOI: 10.1016/s0009-9120(02)00295-3

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome.

Authors:  Dor Mohammad Kordi-Tamandani; Mohammad Hashemi; Nooshin Sharifi; Mahmoud Ali Kaykhaei; Adam Torkamanzehi
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

2.  Paraoxonase 1 status in the Thai population.

Authors:  Wimon Phuntuwate; Chuthamanee Suthisisang; Banhan Koanantakul; Michael I Mackness; Bharti Mackness
Journal:  J Hum Genet       Date:  2005-05-28       Impact factor: 3.172

3.  PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia : Clinical study of possible associations.

Authors:  H Chen; S Ding; M Zhou; X Wu; X Liu; J Liu; Y Wu; D Liu
Journal:  Herz       Date:  2017-08-23       Impact factor: 1.443

Review 4.  Paraoxonase gene polymorphisms, oxidative stress, and diseases.

Authors:  Hong-Liang Li; De-Pei Liu; Chih-Chuan Liang
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

5.  Evaluation of Relationship Between Arylesterase-Based Activity and Genetic Variants of Paraoxonase1 in T2DM Patients within Golestan Province.

Authors:  Safoura Khajeniazi; Raheleh Shakeri; Abdoljalal Marjani
Journal:  Indian J Clin Biochem       Date:  2019-03-05

Review 6.  Exploring the role of paraoxonases in the pathogenesis of coronary artery disease: a systematic review.

Authors:  David Abelló; Elena Sancho; Jordi Camps; Jorge Joven
Journal:  Int J Mol Sci       Date:  2014-11-14       Impact factor: 5.923

7.  Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease.

Authors:  Damrus Tresukosol; Bhoom Suktitipat; Saowalak Hunnangkul; Ruttakarn Kamkaew; Saiphon Poldee; Boonrat Tassaneetrithep; Atip Likidlilid
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

Review 8.  Effects of paraoxonase 1 gene polymorphisms on heart diseases: Systematic review and meta-analysis of 64 case-control studies.

Authors:  Yazmín Hernández-Díaz; Carlos Alfonso Tovilla-Zárate; Isela Esther Juárez-Rojop; Thelma Beatriz González-Castro; Candelario Rodríguez-Pérez; María Lilia López-Narváez; José Manuel Rodríguez-Pérez; José Francisco Cámara-Álvarez
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

9.  Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population.

Authors:  David Corredor-Orlandelli; Santiago Sambracos-Parrado; Santiago Mantilla-García; Josué Tovar-Tirado; Valentina Vega-Ramírez; Santiago David Mendoza-Ayús; Laura Catalina Peña; María Fernanda Leal; Juliana Rodríguez-Carrillo; Juanita León-Torres; Juan Mauricio Pardo-Oviedo; Katherine Parra Abaunza; Nora Contreras Contreras Bravo; Oscar Ortega-Recalde; Dora Janeth Fonseca Mendoza
Journal:  Vasc Health Risk Manag       Date:  2021-11-03

Review 10.  The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis.

Authors:  Debbie A Lawlor; Ian N M Day; Tom R Gaunt; Lesley J Hinks; Patricia J Briggs; Matthew Kiessling; Nick Timpson; George Davey Smith; Shah Ebrahim
Journal:  BMC Genet       Date:  2004-06-23       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.